Showing 81 - 100 results of 254 for search '"macular degeneration', query time: 0.07s Refine Results
  1. 81

    Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes by Ana Catarina Pedrosa, Tiago Sousa, João Pinheiro-Costa, João Beato, Manuel S. Falcão, Fernando Falcão-Reis, Angela Carneiro

    Published 2017-01-01
    “…To evaluate the predictive factors of long-term visual outcomes in neovascular age-related macular degeneration (nAMD) treated with antivascular endothelial growth factor (anti-VEGF) agents. …”
    Get full text
    Article
  2. 82

    Comparison of OCT Angiography Parameters after Administration of Intravitreal Brolucizumab versus Ranibizumab in Exudative Age-related Macular Degeneration by Sanjitha Vilma Moses, Aadithreya Varman, Dinesh Balakumar, Arulmozhi Varman

    Published 2024-12-01
    “…Purpose: To compare the OCT angiography (OCTA)–derived parametric changes before and after intravitreal administration of ranibizumab and brolucizumab in patients with neovascular age-related macular degeneration (ARMD) and to compare the changes between the two groups. …”
    Get full text
    Article
  3. 83

    Charles Bonnet syndrome in patients with geographic atrophy secondary to age-related macular degeneration: a cross-sectional study by Nathalie Skovgaard Eriksen, Nabi Mousavi, Yousif Subhi, Torben Lykke Sørensen, Marie Krogh Nielsen

    Published 2025-01-01
    “…Background: Age-related macular degeneration (AMD) is a prevalent cause of irreversible vision loss among the elderly. …”
    Get full text
    Article
  4. 84

    Association between relative telomere length and a genetic variant of SIRT1 gene and age-related macular degeneration by L.K. Moshetova, O.P. Dmitrenko, O.I. Abramova, N.S. Karpova, K.I. Turkina, I.N. Saburina

    Published 2021-09-01
    “…</i> </p> <p> <i><b>Keywords</b>: age-related macular degeneration, relative telomere length, rs12778366, SIRT1 gene, age-related diseases, buccal epithelium, genetic testing.…”
    Get full text
    Article
  5. 85
  6. 86
  7. 87
  8. 88

    Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept by Juliana Wons, Magdalena A. Wirth, Nicole Graf, Matthias D. Becker, Stephan Michels

    Published 2017-01-01
    “…Retinal pigment epithelium (RPE) loss in neovascular age-related macular degeneration (nAMD) seem to have a linear progression but might be influenced by the treatment. …”
    Get full text
    Article
  9. 89

    Association of age-related macular degeneration on fracture risks among osteoporosis population: a nationwide population-based cohort study by Bing-Yu Chen, Chi Chin Sun, Ting-Shuo Huang, Tsai-Sheng Fu, Chia-Yi Lee, Fang-Ping Chen

    Published 2020-09-01
    “…Objectives Visual impairment is an important risk factor for fracture in the elderly population. Age-related macular degeneration (AMD) is the leading cause of irreversible visual impairment in elderly people. …”
    Get full text
    Article
  10. 90
  11. 91

    Neovascular age-related macular degeneration: disease pathogenesis and current state of molecular biomarkers predicting treatment response—a scoping review by Nikolaos Dervenis, Eleftherios Agorogiannis, Panagiotis Dervenis

    Published 2024-05-01
    “…Age-related macular degeneration is a major cause of blindness, and the development of anti-vascular endothelial growth factor (VEGF) intravitreal treatments has revolutionised the management of the disease. …”
    Get full text
    Article
  12. 92
  13. 93

    Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany by Joachim Wachtlin, Georg Spital, Steffen Schmitz-Valckenberg, Sandra Liakopoulos, Jessica Vögeler, Bettina Müller, Focke Ziemssen, Ocean study group

    Published 2020-01-01
    “…To date, there are limited prospective real-world data on the impact of optical coherence tomography (OCT) diagnostics on treatment outcomes in neovascular age-related macular degeneration (nAMD). Therefore, the prospective, noninterventional OCEAN study (NCT02194803) evaluated the use of OCT imaging and its impact on functional outcomes in Germany. …”
    Get full text
    Article
  14. 94

    Three-Year Outcomes of Patients with Neovascular Age-Related Macular Degeneration Treated with Aflibercept under the National Health Insurance Program in Taiwan by Kang-Jung Lo, Jin-Yu Chang, Hsin-Yi Chang, Shih-Hwa Chiou, De-Kuang Hwang, Shih-Jen Chen

    Published 2020-01-01
    “…To observe and analyze the long-term outcomes of patients with neovascular age-related macular degeneration (nAMD) treated with aflibercept monotherapy under the National Health Insurance (NHI) program in Taiwan. …”
    Get full text
    Article
  15. 95
  16. 96
  17. 97
  18. 98
  19. 99
  20. 100

    Efficacy Comparison of Intravitreal Anti-VEGF Therapy for Three Subtypes of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis by Jianqing Li, Jiayi Xu, Yiyi Chen, Jiaju Zhang, Yihong Cao, Peirong Lu

    Published 2018-01-01
    “…Intravitreal antivascular endothelial growth factor (anti-VEGF) therapy has been widely used for the treatment of neovascularization (NV) secondary to age-related macular degeneration (AMD). This study aimed to compare the efficacy among different subtypes of neovascular age-related macular degeneration (nAMD). …”
    Get full text
    Article